Advertisement
Screener

NEXENTIS TECHNOLOGIES INC. (NXTS) Noncontrolling Interest, Increase from Subsidiary Equity Issuance

2.8 / 5 stars · 68/120 Roast Me

NEXENTIS TECHNOLOGIES INC. Noncontrolling Interest, Increase from Subsidiary Equity Issuance

NEXENTIS TECHNOLOGIES INC. (NXTS) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $8.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Shareholders' Equity

us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2026-08-13

  • NEXENTIS TECHNOLOGIES INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2026-06-30 was $8.00K.
  • NEXENTIS TECHNOLOGIES INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2025-09-30 was $68.00K.
  • NEXENTIS TECHNOLOGIES INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2025 was $80.00K.
  • NEXENTIS TECHNOLOGIES INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2023 was $160.00K.
Period endNoncontrolling Interest, Increase from Subsidiary Equity Issuance 3 monthNoncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month
2026-06-30$8.00K
10-Q · filed 2026-08-13
2025-12-31$80.00K
10-K · filed 2026-03-31
2025-09-30$68.00K
10-Q · filed 2025-11-13
2023-12-31$160.00K
10-K · filed 2025-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02